Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
One Percent Rule Checklist For Safer Forex Trading Risk 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
SAN FRANCISCO, April 12, 2017 -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2017 first quarter financial results after the market closes on Wednesday, April 26, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, April 26, 2017, to discuss the financial results and other business developments.
Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 5223865. To listen to the live call via Invuity's website, go to www.invuity.com, in the Events & Presentations section. A webcast replay of the call will be available following the conclusion of the call in the Events & Presentations section of the website.
About Invuity®
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include women’s health, encompassing breast cancer and breast reconstructive surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
